This PFA is for you: Surprising amount of ‘forever chemicals' found in some American beers, study finds
It reports that some U.S. beers contain higher than the Environmental Protection Agency's maximum safe levels of polyfluoroalkyl substances, which have come to be known as " forever chemicals" due to the fact that they don't naturally break down or pass through the body.
Other recent reports have found PFAS are present in drinking water across the globe, and the study's author decided to see if those same chemicals were making their way into beer.
"As an occasional beer drinker myself, I wondered whether PFAS in water supplies were making their way into our pints. I hope these findings inspire water treatment strategies and policies that help reduce the likelihood of PFAS in future pours," wrote lead researcher Jennifer Hoponick Redmon.
Breweries do use water filtration and treatment systems to ensure only quality water is being used in their brews, but those systems don't typically block PFAS from entering into the system.
Redmon and her team modified an EPA testing tool analyzing PFAS in drinking water and used it to test 23 U.S. beers.
They selected beers from areas where water-system contamination has already been documented, as well as beers from areas with unknown water systems.
According to the study's findings, some breweries in North Carolina, California, and Michigan had elevated levels of PFAS in their beers.
In 95 percent of the beer tested, PFAS with perfluorooctanesulfonate and perfluorooctanoic acid — both forever chemicals — were present.
Beers from outside the U.S. were also tested. One beer from Holland and two from Mexico were tested, and were found to be less likely to contain PFAS.
"Our findings indicate a strong link between PFAS in drinking water and beer, with beers brewed in areas with higher PFAS in local drinking water translating to higher levels of PFAS in beer, showing that drinking water is a primary route of PFAS contamination in beer," the research team determined.
Last fall, researchers from the University of Birmingham, Southern University of Science and Technology, Shenzhen, and Hainan University, Haikou, published a study that found that forever chemicals were present in water across the world.
PFAS can accumulate in the bodies of living organisms and have been linked to severe health conditions. They are used in different products like pesticides, non-stick cookware, food packaging and cosmetics, and can enter wastewater through many day-to-day activities. Government regulation has banned some, while the use of others is still widespread, with their toxic effects yet to be fully investigated.
They also revealed a wide range of PFAS contamination for target PFAS, beginning at 63 percent of bottled waters tested.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 hours ago
- Reuters
Exclusive: Intel's new CEO explores big shift in chip manufacturing business
SAN FRANCISCO, July 1 (Reuters) - Intel's (INTC.O), opens new tab new chief executive is exploring a big change to its contract manufacturing business to win major customers, two people familiar with the matter told Reuters, in a potentially expensive shift from his predecessor's plans. If implemented, the new strategy for what Intel calls its "foundry" business would entail no longer marketing certain chipmaking technology, which the company had long developed, to external customers, the people said. Since taking in March, CEO Lip-Bu Tan has moved fast to cut costs and find a new path to revive the ailing U.S. chipmaker. By June, he started voicing that a manufacturing process that prior CEO Pat Gelsinger bet heavily on, known as 18A, was losing its appeal to new customers, said the sources, who spoke on condition of anonymity. To put aside external sales of 18A and its variant 18A-P, manufacturing processes that have cost Intel billions of dollars to develop, the company would have to take a write-off, one of the people familiar with the matter said. Industry analysts contacted by Reuters said such a charge could amount to a loss of hundreds of millions, if not billions, of dollars. Intel declined to comment on such "hypothetical scenarios or market speculation." It said the lead customer for 18A has long been Intel itself, and it aims to ramp production of its "Panther Lake" laptop chips later in 2025, which it called the most advanced processors ever designed and manufactured in the United States. Persuading outside clients to use Intel's factories remains key to its future. As its 18A fabrication process faced delays, rival TSMC's ( opens new tab N2 technology has been on track for production. Tan's preliminary answer to this challenge: focus more resources on 14A, a next-generation chipmaking process where Intel expects to have advantages over Taiwan's TSMC, the two sources said. The move is part of a play for big customers like Apple (AAPL.O), opens new tab and Nvidia (NVDA.O), opens new tab, which currently pay TSMC to manufacture their chips. Tan has tasked the company with teeing up options for discussion with Intel's board when it meets as early as this month, including whether to stop marketing 18A to new clients, one of the two sources said. The board might not reach a decision on 18A until a subsequent autumn meeting in light of the matter's complexity and the enormous money at stake, the person said. Intel declined to comment on what it called rumor. In a statement, it said: "Lip-Bu and the executive team are committed to strengthening our roadmap, building trust with our customers, and improving our financial position for the future. We have identified clear areas of focus and will take actions needed to turn the business around." Last year was Intel's first unprofitable year since 1986. It posted a net loss attributable to the company of $18.8 billion for 2024. The Intel chief executive's deliberations show the enormous risks - and costs - under consideration to move the storied U.S. chipmaker back onto solid footing. Like Gelsinger, Tan inherited a company that had lost its manufacturing edge and fell behind on crucial technology waves of the past two decades: mobile computing and artificial intelligence. The company is targeting high-volume production later this year for 18A with its internal chips, which are widely expected to arrive ahead of external customer orders. Meanwhile, delivering 14A in time to win major contracts is by no means certain, and Intel could choose to stick with its existing plans for 18A, one of the sources said. Intel is tailoring 14A to key clients' needs to make it successful, the company said. Tan's review of whether to focus clients on 14A involves the contract chipmaking portion of Intel, or foundry, which makes chips for external customers. Regardless of a board decision, Intel will make chips via 18A in cases where its plans are already in motion, the people familiar with the matter said. This includes using 18A for Intel's in-house chips that it already designed for that manufacturing process, the people said. Intel also will produce a relatively small volume of chips that it has guaranteed for (AMZN.O), opens new tab and Microsoft (MSFT.O), opens new tab via 18A, with deadlines that make it unrealistic to wait for the development of 14A. Amazon and Microsoft did not immediately comment on the matter. Intel said it will deliver on its customer commitments. Tan's overall strategy for Intel remains nascent. So far, he has updated his leadership team, bringing in new engineering talent, and he has worked to shrink what he considered bloated and slow-moving middle management. Shifting away from selling 18A to foundry customers would represent one of his biggest moves yet. The 18A manufacturing process includes a novel method of delivering energy to chips and a new type of transistor. Together, these enhancements were meant to let Intel match or exceed TSMC's capabilities, Intel executives have previously said. However, according to some industry analysts, the 18A process is roughly equivalent to TSMC's so-called N3 manufacturing technology, which went into high-volume production in late 2022. If Intel follows Tan's lead, the company would focus its foundry employees, design partners and new customers on 14A, where it hopes for a better chance to compete against TSMC. Tan has drawn on extensive contacts and customer relationships built over decades in the chip industry to arrive at his view on 18A, the two sources said.
The Independent
3 hours ago
- The Independent
20 states sue after the Trump administration releases private Medicaid data to deportation officials
The Trump administration violated federal privacy laws when it turned over Medicaid data on millions of enrollees to deportation officials last month, California Attorney General Rob Bonta alleged on Tuesday, saying he and 19 other states' attorneys general have sued over the move. Health secretary Robert F. Kennedy Jr.'s advisers ordered the release of a dataset that includes the private health information of people living in California, Illinois, Washington state, and Washington, D.C., to the Department of Homeland Security last month, The Associated Press first reported last month. All of those states allow non-U.S. citizens to enroll in Medicaid programs that pay for their expenses using only state taxpayer dollars. The unusual data sharing of private health information, including addresses, names, social security numbers, immigration status, and claims data for enrollees in those states, was released to deportation officials as they accelerated enforcement efforts across the country. The data could be used to help the Department of Homeland Security locate migrants in its mass deportation campaign, experts said. Bonta said the Trump administration's data release violates federal health privacy protection laws, including the Health Insurance Portability and Accountability Act (HIPAA). 'This is about flouting seven decades of federal law policy and practice that have made it clear that personal healthcare data is confidential and can only be shared in certain narrow circumstances that benefit the public's health or the Medicaid program,' Bonta said during a news conference on Tuesday. The Trump administration has sought to arm deportation officials with more data on immigrants. In May, for example, a federal judge refused to block the Internal Revenue Service from sharing immigrants' tax data with Immigration and Customs Enforcement to help agents locate and detain people living without legal status in the U.S. The move to shore up the federal government's data on immigrant Medicaid enrollees appears to have been set in motion in May, when the Centers for Medicare and Medicaid Services announced it would be reviewing some states rolls to ensure federal funds have not been used to pay for coverage for people with 'unsatisfactory immigration status.' As part of the review, CMS asked California, Washington and Illinois to share details about non-U.S. citizens who have enrolled in their state's Medicaid program, according to a June 6 memo signed by Medicaid Deputy Director Sara Vitolo that was obtained by the AP. The memo was written by several CMS officials under Vitolo's supervision, according to sources familiar with the process. CMS officials attempted to fight the data sharing request from Homeland Security, saying that to do so would violate federal laws, including the Social Security Act and the Privacy Act of 1974, according to the memo. The legal arguments outlined in the memo were not persuasive to Trump appointees at HHS, which oversees the Medicaid agency. Four days after the memo was sent, on June 10, HHS officials directed the transfer of 'the data to DHS by 5:30 ET today,' according to email exchanges obtained by AP. HHS is 'aggressively cracking down on states that may be misusing federal Medicaid funds,' agency spokesman Andrew Nixon said in a statement. The agency has not provided details on DHS' role in the effort. Nixon also defended the legality of releasing the data to DHS. 'HHS acted entirely within its legal authority – and in full compliance with all applicable laws – to ensure that Medicaid benefits are reserved for individuals who are lawfully entitled to receive them,' he said in the statement. Dozens of Democratic members of Congress — in both the House and Senate — have sent letters to the involved agencies, demanding that data sharing cease and that Homeland Security destroy the information it has received so far. — Associated Press writer Olga R. Rodriguez in San Francisco contributed.
Reuters
5 hours ago
- Reuters
Corona beer maker Constellation Brands misses quarterly estimates amid tariff woes
July 1 (Reuters) - Constellation Brands (STZ.N), opens new tab missed first-quarter sales and profit estimates on Tuesday, as fears of rising tariffs and economic uncertainty prompted consumers to reduce purchases of beers and wines. U.S. alcoholic beverage makers have faced a double blow from the Trump administration's shifting trade policies, a challenge that comes at a time when the industry is already grappling with tepid demand. Corona beer maker reported net sales of $2.52 billion for the quarter ended May 31, compared with analysts' average estimate of $2.55 billion, according to data compiled by LSEG. Tariffs on beer imports, along with the inclusion of beer cans under aluminum tariffs, have impacted liquor makers such as Constellation Brands and Molson Coors (TAP.N), opens new tab. Last month, U.S. President Trump announced plans to double tariffs on imported steel and aluminum to 50% from 25%, intensifying pressure on global steel producers and escalating the trade war. Meanwhile, Constellation Brands has experienced a significant slowdown in beer consumption, particularly among its Hispanic consumers, following Trump's immigration crackdown. The company's beer business, its largest revenue contributor, reported a 2.6% decline in quarterly depletion volume — the rate at which products are sold — driven by declines in brands such as Modelo Especial and Corona Extra. Its beer depletions rose 6.4% a year ago. Sequential price increases and cost management measures were offset by higher expenses, including increased costs from aluminum tariffs and marketing expenditures. The company's quarterly operating margins at its beer business fell 150 basis points to 39.1%. Constellation reported comparable profit of $3.22 per share for the quarter, below estimates of $3.31. Shares of the company, which maintained its annual enterprise organic sales and profit forecast, were marginally lower in extended trading.
